Experience the Power of Smarter Trials at Booth #6
Clinical development isn’t getting any easier—resources are constrained, protocols are more complex, and timelines leave little room for error. The advantage? Seeing what’s ahead before it happens.
At SCOPE Europe, step into a new era of trial strategy with Trial IntelX™—the first solution designed to unify trial intelligence at scale. By turning real-world trial data into clear, actionable insight, Trial IntelX™ helps you move from reactive decisions to proactive strategy. Built on one of the industry’s most comprehensive datasets—spanning 80,000+ protocols and 40,000+ benchmarked trials—Trial IntelX™ equips your team to:
- Anticipate risks early and course-correct with confidence
- Design smarter protocols grounded in real-world benchmarks
- Make faster, data-backed decisions at critical inflection points
- Replace uncertainty with clarity through transparent, trusted insights
This isn’t just more data—it’s a better way to run trials.
Visit Booth #6 or schedule a demo to see how unified trial intelligence is helping sponsors, CROs, and sites unlock faster, more predictable outcomes.
Join Our Expert Session
Don’t miss our 25-minute presentation – Closing the Trial Design: Execution Gap Leveraging AI Powered by Digitized Protocol Intelligence and Proprietary Operational Data: Join WCG’s Mette Andersen as she explores why trial success begins with protocol quality, yet critical feasibility and execution decisions are still too often driven by static documents, fragmented data, and subjective assumptions. Learn how WCG’s Trial IntelX™ uses digitized protocol intelligence, AI-powered enrollment forecasting, and scenario modeling to identify operational risks before the first participant is enrolled. The result is more feasible study designs, fewer protocol amendments, streamlined ethical review, and greater confidence in trial execution.